SIEMENS: All set for next leg of Journey!Siemens ready to breakout from the Top of a Long Term Channel - Buyers are very aggressively pushing the prices up.
"Three Soldiers" pattern in Weekly chart from previous base.
PS: Results due today.
Holding it at from 3000 levels when the stock came out from a pretty good base.
New positions to be taken after consolidation and a break out above the channel.
PS: Think about R:R before any entry is taken.
Siemenslong
Siemens Long Siemens trading near support area if it's hold here and breaking up side with good move and close above 2200 then we can enter on this stock with strict sl of 2125 on CB.
hold this position for at least December ending we can get a good move upside.
we can get minimum upside 2300/2400 we can trade this trade as a swing trade with 1:2 risk reward ratio.
R-0189 BUY SIEMENS INDIA (Broke first resistance 1212)Buy: 1230-1233
SL 1207
TGT 1278
Reason: Just cross the TK line + MACD cross over + Above VWAP followed by crossing first resistance 1212 so second resistance is 1263 so we expect to move in the range >1250 and if breaks second resistance then move towards 1300.
SHL Siemens potential path into Germany’s benchmark DAX30 indexThe $16.4 billion purchase of Varian Medical Systems not only gives Siemens Healthineers AG an entry into cancer treatment -- one of the hottest areas in medical technology -- but also opens a potential path into Germany’s benchmark DAX index.
“We’ll create additional free float which eventually will lift us into the DAX,” Chief Executive Officer Bernd Montag said in an interview with Bloomberg TV. “We are very certain about this transaction, it’s the right time, and we are super confident about financing.”
The Erlangen, Germany-based maker of MRI machines and laboratory equipment announced Sunday it’s offering $177.50 a share for Palo Alto, California-based Varian, 24% more than its closing price on Friday. Bloomberg was first to report the offer on Saturday.
With Varian, Healthineers will gain market share in devices and software used for cancer therapy. Recent developments in radiation therapy, coupled with more precise imaging, have been linked to lower cancer death rates, which Montag said the company is keen to capitalize on.
The deal has “clear strategic rationale,” Citigroup analyst Kate Kalashnikova said in a note. “The combined company will have the most comprehensive cancer portfolio in the industry.”
The deal is the biggest health-care acquisition this year.
Source: Bloomberg
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
Siemens - WXY FormationThe Siemens-share could be in a WXY formation since May 2017.
There should already be the (a) the Y nearing completion and in the range 96-97€, with a two-digit daily closing price, then turn back up.
This upswing would have to be continued until the beginning of the second quarter of 2019 before the low is formed by the middle of the year 2019.
Have set with alarm clock to 97€ and then look for the trend reversal.
Greetz from an Eichsfelder from Hanover.
Stefan Bode